What is the diagnosis and management for a patient with fever, pruritic generalized rash, palmar erythema and swelling, joint pains, myalgias, and mouth ulcers near the soft palate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis: Adult-Onset Still's Disease (AOSD)

This clinical presentation is most consistent with Adult-Onset Still's Disease, characterized by the classic triad of high-spiking fever, salmon-pink evanescent rash, and arthralgia/myalgia, along with mouth ulcers. 1, 2

Clinical Features Supporting AOSD Diagnosis

The patient presents with the hallmark manifestations of AOSD:

  • Fever: Daily high-spiking fever (typically ≥39°C) is present in 95-100% of AOSD cases and represents a cardinal feature 1, 2

  • Characteristic Rash: The pruritic generalized rash with palmar involvement is consistent with the salmon-pink, evanescent maculopapular eruption seen in 72.7% of AOSD patients (range 51-87% across major series) 1. The rash is typically pruritic, predominantly affects proximal limbs and trunk, and can be confused with drug allergy 1

  • Joint Involvement: Arthralgia and myalgia are present in 64-100% of AOSD cases, with polyarticular involvement being typical 1

  • Myalgia: Generalized myalgia occurs in 56-84% of cases and typically appears with fever exacerbations 1

  • Mouth Ulcers: Oral manifestations can occur in AOSD, though sore throat is more commonly reported (38-92% of cases) 1

Diagnostic Workup

Immediate laboratory investigations should include:

  • Complete blood count: Look for leukocytosis (often >15×10⁹/L in 50% of patients, with 37% having WBC >20×10⁹/L), neutrophilia, anemia of chronic disease, and thrombocytosis 1, 2

  • Inflammatory markers: ESR and CRP are elevated in virtually all patients 1, 2

  • Serum ferritin: Markedly elevated levels (often 4,000-30,000 ng/mL, sometimes up to 250,000 ng/mL) with 80% sensitivity when elevated 5-fold above normal 1, 2

  • Glycosylated ferritin fraction: When <20% combined with 5-fold ferritin elevation, sensitivity is 43% but specificity rises to 93% 1

  • Liver function tests: Hepatomegaly and abnormal liver biochemistry occur in 50-75% of patients 1, 2

  • IL-18 and/or S100 proteins (calprotectin): Recommended by 2024 EULAR/PReS guidelines to support diagnosis 2

Critical Differential Diagnoses to Exclude

Rocky Mountain Spotted Fever (RMSF) must be ruled out urgently given the overlapping features of fever, rash with palmar involvement, myalgia, and potential mortality of 5-10% if untreated 1. However, RMSF typically:

  • Has a 3-12 day incubation period after tick exposure 1
  • Rash begins on ankles/wrists/forearms and spreads centrally, appearing 2-4 days after fever onset 1
  • Becomes petechial by day 5-6 (not pruritic) 1
  • Causes thrombocytopenia and hyponatremia 1

Other important exclusions:

  • Systemic Lupus Erythematosus: Check ANA, anti-dsDNA, complement levels. SLE typically has positive ANA with diverse systemic manifestations 3, 4

  • Infections: Blood cultures, throat culture for Group A Streptococcus (to exclude acute rheumatic fever, though erythema marginatum is non-pruritic) 5, 6

  • Malignancy and other immune-mediated diseases: Must be carefully excluded per 2024 EULAR/PReS guidelines 2

Management Approach

Initial treatment for AOSD:

  • NSAIDs: First-line therapy for mild disease, though liver dysfunction may be a cofactor requiring monitoring 1

  • Corticosteroids: Oral prednisolone 0.5-1 mg/kg/day for moderate to severe disease 1

  • Monitor for Macrophage Activation Syndrome (MAS): A life-threatening complication that can occur at onset, during treatment, or in remission. Watch for pancytopenia, which necessitates prompt immunosuppressive treatment 1, 2

Critical Pitfalls to Avoid

  • Do not wait for arthritis to develop: The Yamaguchi criteria do not require arthritis for AOSD diagnosis, and delaying diagnosis while waiting for arthritis can lead to unnecessary and potentially deleterious delays 2

  • Do not dismiss the diagnosis based on age: While called "adult-onset," this can occur in young adults like this 25-year-old patient 1

  • Do not attribute liver dysfunction solely to NSAIDs: Hepatic involvement is part of AOSD itself in 50-75% of cases 1

  • Monitor for MAS continuously: This complication requires vigilance throughout the disease course, not just at presentation 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis and Management of Still's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Systemic Lupus Erythematosus Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

SLE in a Male Patient Presented Initially as Rowell's Syndrome.

The Journal of the Association of Physicians of India, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.